Director, Clinical Site and Trial Operations

United States·Bothellexecutive

OtherDirector

1 views0 saves0 applied

Apply Now

Quick Summary

Overview

Company Overview Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies.

Technical Tools

OtherDirector

Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, supported by a leadership team with deep experience in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugates. Our pipeline includes varegacestat, an investigational gamma secretase inhibitor for which an NDA has been submitted to the U.S. FDA; IM-1021, a clinical-stage ROR1 ADC; IM-3050, an IND-cleared FAP-targeted radiotherapy; and IM-1617, an IND-cleared solid tumor ADC. We are also advancing a broad portfolio of early-stage ADCs pursuing undisclosed solid tumor targets.

Position Overview

The Director, Clinical Site and Trial Operations (CSTO) provides strategic and operational leadership for Immunome’s clinical trials, overseeing all aspects of site-facing trial execution—from planning and initiation through site and trail closeout—ensuring studies are conducted in compliance with regulatory requirements and corporate objectives.

The Director will lead and develop a high-performing CSTO team, partner closely with Clinical Project Delivery on trial delivery, oversee day-to-day vendor management, and establish site-facing best practices to ensure operational excellence. The Director will collaborate with cross-functional stakeholders, including Clinical Development, Regulatory Affairs, Medical Affairs, CMC, and Quality, to ensure the successful execution of Immunome’s clinical trials.

The Director may also lead one or more outsourced trials and/or lead US site management and trial operations activities on mixed model studies where US site management and monitoring is conducted in-house, and ex-US is outsourced.

Responsibilities